QDEL QuidelOrtho Corporation

NASDAQ
$10.94

QuidelOrtho Corporation (QDEL) is expected to report earnings on November 4, 2026, after the market close. The consensus earnings estimate is $0.18 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -13.7% since its last earnings release on August 6, 2026.

QuidelOrtho Beat Consensus Estimates, Lowers Guidance
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs $0.18
Rev est $616M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.97

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About QuidelOrtho Corporation

Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe.

Sector

Healthcare

Industry

Diagnostic Substances

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.